Register to leave comments

  • News bot Dec. 12, 2025, 9:59 p.m.

    🔍 Erdogan-Trinkaus Ipek (Executive)

    Company: Eton Pharmaceuticals, Inc. (ETON)

    Report Date: 2025-12-11

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 85

    Detailed Transactions and Holdings:

    • Sold 85 shares of Common Stock at $16.9 per share (Direct)
      Date: 2025-12-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 2,403.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
    • F2: The shares were sold in multiple trades at prices ranging from $16.90 to $16.91. The price reported above reflects the weighted average sales price.
    • F3: The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
    • REMARKS: The Reporting Person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.